Literature DB >> 28804905

The evolution of paroxysmal nocturnal haemoglobinuria depends on intensity of immunosuppressive therapy.

Taha Bat1, Omnia N Abdelhamid1, Suresh K Balasubramanian1, Aly Mai1, Tomas Radivoyevitch2, Michael Clemente1, Jaroslaw P Maciejewski1.   

Abstract

Entities:  

Keywords:  aplastic anaemia; clonal evolution; immunosuppressive therapy; paroxysmal nocturnal haemoglobinuria

Mesh：

Year:  2017        PMID： 28804905      PMCID： PMC5812827          DOI： 10.1111/bjh.14862

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this little PIG-A goes "Why? Why? Why?".

Authors:  N S Young; J P Maciejewski
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Relationship between bone marrow failure syndromes and the presence of glycophosphatidyl inositol-anchored protein-deficient clones.

Authors:  J P Maciejewski; C Rivera; H Kook; D Dunn; N S Young
Journal:  Br J Haematol       Date:  2001-12       Impact factor: 6.998

3.  Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.

Authors:  J P Maciejewski; D Follmann; R Nakamura; Y Saunthararajah; C E Rivera; T Simonis; K E Brown; J A Barrett; N S Young
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113
  3 in total
  6 in total

1.  Potential impact of complement regulator deficiencies on hemolytic reactions due to minor ABO-mismatched transfusions.

Authors:  Priyanka Pandey; Waseem Q Anani; Jerome L Gottschall; Gregory A Denomme
Journal:  Blood Adv       Date:  2017-10-11

2.  Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.

Authors:  Lova Sun; Daria V Babushok
Journal:  Blood       Date:  2020-07-02       Impact factor: 22.113

3.  Significance of paroxysmal nocturnal hemoglobinuria clone in immunosuppressive therapy for children with severe aplastic anemia.

Authors:  Jun Li; Su-Yu Zong; Zi-Xi Yin; Yang-Yang Gao; Li-Peng Liu; Yang Wan; Yang Lan; Xiao-Wen Gong; Xiao-Fan Zhu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-03-15

Review 4.  Aplastic Anemia.

Authors:  Neal S Young
Journal:  N Engl J Med       Date:  2018-10-25       Impact factor: 91.245

5.  Time and residual hematopoiesis are crucial for PNH clones escape in hepatitis-associated aplastic anemia.

Authors:  Wenrui Yang; Xin Zhao; Guangxin Peng; Li Zhang; Liping Jing; Kang Zhou; Yang Li; Lei Ye; Yuan Li; Jianping Li; Huihui Fan; Yang Yang; Fengkui Zhang
Journal:  Ann Hematol       Date:  2021-07-16       Impact factor: 3.673

6.  Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria.

Authors:  Carmelo Gurnari; Amy C Graham; Alexey Efanov; Simona Pagliuca; Jibran Durrani; Hassan Awada; Bhumika J Patel; Alan E Lichtin; Valeria Visconte; Mikkael A Sekeres; Jaroslaw P Maciejewski
Journal:  Blood Cells Mol Dis       Date:  2020-12-08       Impact factor: 3.039
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.